Search research articles
Contact Us
Filters
Showing results (51-60 of 136) with videos related to
Page
of 14
Sort By:
Pharmaceutics
|
May 27, 2023
Challenges and Opportunities in the Oral Delivery of Recombinant Biologics
Solene Masloh, Maxime Culot, Fabien Gosselet, et al.
Pharmaceuticals (Basel, Switzerland)
|
February 26, 2022
Laboratory Selection of Trypanosomatid Pathogens for Drug Resistance
Sabina Beilstein, Radhia El Phil, Suzanne Sherihan Sahraoui, et al.
Journal of Medicinal Chemistry
|
October 31, 2003
Synthesis and biological evaluation of 5-substituted derivatives of the potent antiherpes agent (north)-methanocarbathymine
Pamela Russ, Pierre Schelling, Leonardo Scapozza, et al.
Plos Neglected Tropical Diseases
|
August 27, 2009
Adenosine Kinase of T. b. Rhodesiense identified as the putative target of 4-[5-(4-phenoxyphenyl)-2H-pyrazol-3-yl]morpholine using chemical proteomics
Sabine Kuettel, Marc Mosimann, Pascal Mäser, et al.
Chemistry & Biodiversity
|
December 29, 2006
Synthesis and characterization of a C6 nucleoside analogue for the in vivo imaging of the gene expression of herpes simplex virus type-1 thymidine kinase (HSV1 TK)
Anass Johayem, Silvana Raić-Malić, Katia Lazzati, et al.
Oncotarget
|
March 10, 2015
NPM/ALK mutants resistant to ASP3026 display variable sensitivity to alternative ALK inhibitors but succumb to the novel compound PF-06463922
Luca Mologni, Monica Ceccon, Alessandra Pirola, et al.
The Journal of Experimental Medicine
|
February 27, 2008
Caspase-8 is activated by cathepsin D initiating neutrophil apoptosis during the resolution of inflammation
Sébastien Conus, Remo Perozzo, Thomas Reinheckel, et al.
Cells
|
January 24, 2025
A Novel, Cell-Compatible Hyaluronidase Activity Assay Identifies Dextran Sulfates and Other Sulfated Polymeric Hydrocarbons as Potent Inhibitors for CEMIP
Anja Schmaus, Sofia Spataro, Paul Sallmann, et al.
Protein Expression and Purification
|
February 14, 2006
High-level expression and purification of human thymidine kinase 1: quaternary structure, stability, and kinetics
Markus S Birringer, Remo Perozzo, Elvan Kut, et al.
The Lancet. Oncology
|
February 8, 2003
Molecular mechanisms of resistance to imatinib in Philadelphia-chromosome-positive leukaemias
Carlo B Gambacorti-Passerini, Rosalind H Gunby, Rocco Piazza, et al.
Page
of 14
Search research articles
Search
Showing results (51-60 of 136) with videos related to
Sort By:
Page
of 14
Pharmaceutics
|
May 27, 2023
Challenges and Opportunities in the Oral Delivery of Recombinant Biologics
Solene Masloh, Maxime Culot, Fabien Gosselet, et al.
Pharmaceuticals (Basel, Switzerland)
|
February 26, 2022
Laboratory Selection of Trypanosomatid Pathogens for Drug Resistance
Sabina Beilstein, Radhia El Phil, Suzanne Sherihan Sahraoui, et al.
Journal of Medicinal Chemistry
|
October 31, 2003
Synthesis and biological evaluation of 5-substituted derivatives of the potent antiherpes agent (north)-methanocarbathymine
Pamela Russ, Pierre Schelling, Leonardo Scapozza, et al.
Plos Neglected Tropical Diseases
|
August 27, 2009
Adenosine Kinase of T. b. Rhodesiense identified as the putative target of 4-[5-(4-phenoxyphenyl)-2H-pyrazol-3-yl]morpholine using chemical proteomics
Sabine Kuettel, Marc Mosimann, Pascal Mäser, et al.
Chemistry & Biodiversity
|
December 29, 2006
Synthesis and characterization of a C6 nucleoside analogue for the in vivo imaging of the gene expression of herpes simplex virus type-1 thymidine kinase (HSV1 TK)
Anass Johayem, Silvana Raić-Malić, Katia Lazzati, et al.
Oncotarget
|
March 10, 2015
NPM/ALK mutants resistant to ASP3026 display variable sensitivity to alternative ALK inhibitors but succumb to the novel compound PF-06463922
Luca Mologni, Monica Ceccon, Alessandra Pirola, et al.
The Journal of Experimental Medicine
|
February 27, 2008
Caspase-8 is activated by cathepsin D initiating neutrophil apoptosis during the resolution of inflammation
Sébastien Conus, Remo Perozzo, Thomas Reinheckel, et al.
Cells
|
January 24, 2025
A Novel, Cell-Compatible Hyaluronidase Activity Assay Identifies Dextran Sulfates and Other Sulfated Polymeric Hydrocarbons as Potent Inhibitors for CEMIP
Anja Schmaus, Sofia Spataro, Paul Sallmann, et al.
Protein Expression and Purification
|
February 14, 2006
High-level expression and purification of human thymidine kinase 1: quaternary structure, stability, and kinetics
Markus S Birringer, Remo Perozzo, Elvan Kut, et al.
The Lancet. Oncology
|
February 8, 2003
Molecular mechanisms of resistance to imatinib in Philadelphia-chromosome-positive leukaemias
Carlo B Gambacorti-Passerini, Rosalind H Gunby, Rocco Piazza, et al.
Page
of 14